CALR3 Gene Cardiomyopathy familial hypertrophic type 19 Genetic Test sale cost 4400 AED
DMD Gene Cardiomyopathy dilated type 3B Genetic Test sale cost 4400 AED DMD Gene Cardiomyopathy dilated type 3B Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
MYLK2 Gene Cardiomyopathy hypertrophic midventricular digenic Genetic Test sale cost 4400 AED MYLK2 Gene Cardiomyopathy hypertrophic midventricular digenic Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

CALR3 Gene Cardiomyopathy familial hypertrophic type 19 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CALR3 Gene Cardiomyopathy Familial Hypertrophic Type 19 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the CALR3 gene that are associated with Familial Hypertrophic Cardiomyopathy (FHC) Type 19. This condition is a form of heart disease that is inherited in an autosomal dominant pattern, characterized by the thickening of the heart’s muscle tissue which can lead to heart failure and other complications.

The test is particularly important for individuals with a family history of cardiomyopathy or those exhibiting symptoms related to heart muscle disorders, as it can provide crucial information for diagnosis, treatment planning, and risk assessment for family members. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific genetic mutations in the CALR3 gene known to contribute to this condition.

At DNA Labs UAE, the cost for the CALR3 Gene Cardiomyopathy Familial Hypertrophic Type 19 Genetic Test is set at 4400 AED. This investment includes the cost of sample collection, genetic analysis, and a comprehensive report that outlines the findings. The results from this test can empower patients and their healthcare providers with the knowledge needed to make informed decisions about management strategies, including lifestyle adjustments, medical surveillance, and potential treatment options to mitigate the impact of the condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CALR3 Gene Cardiomyopathy Familial Hypertrophic Type 19 Genetic Test

Welcome to DNA Labs UAE, where we offer the CALR3 Gene Cardiomyopathy Familial Hypertrophic Type 19 Genetic Test. This test is specifically designed to identify mutations in the CALR3 gene associated with familial hypertrophic cardiomyopathy (FHC) type 19.

Test Components

The CALR3 Gene Cardiomyopathy Familial Hypertrophic Type 19 Genetic Test includes the following components:

  • Test Name: CALR3 Gene Cardiomyopathy Familial Hypertrophic Type 19 Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Cardiovascular Pneumology Disorders
  • Doctor: Cardiologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the CALR3 Gene Cardiomyopathy Familial Hypertrophic Type 19 Genetic Test, it is important to provide the following information:

  • Clinical History of Patient who is going for CALR3 Gene Cardiomyopathy, familial hypertrophic type 19 NGS Genetic DNA Test
  • A Genetic Counselling session to draw a pedigree chart of family members affected with CALR3 Gene Cardiomyopathy, familial hypertrophic type 19 NGS Genetic DNA Test gene CALR3

Test Details

The CALR3 Gene Cardiomyopathy Familial Hypertrophic Type 19 Genetic Test is specifically used to identify mutations in the CALR3 gene associated with familial hypertrophic cardiomyopathy (FHC) type 19. FHC is a genetic disorder that thickens the heart muscle, making it harder for the heart to pump blood effectively. FHC type 19 is specifically caused by mutations in the CALR3 gene.

Next-Generation Sequencing (NGS) technology is utilized in this test. NGS allows for the simultaneous sequencing of multiple genes or even the entire genome. In the context of CALR3 gene cardiomyopathy, NGS is used to analyze the DNA of an individual and identify any mutations or variations in the CALR3 gene that may be associated with the development of FHC type 19.

This genetic test is valuable in diagnosing individuals with familial hypertrophic cardiomyopathy type 19, particularly in cases where the symptoms are unclear or when there is a family history of the condition. It can also be used for genetic counseling and to assess the risk of passing on the condition to future generations.

It is crucial to note that genetic testing should always be done under the guidance of a healthcare professional or genetic counselor who can provide appropriate counseling and interpretation of the results.

Test Name CALR3 Gene Cardiomyopathy familial hypertrophic type 19 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CALR3 Gene Cardiomyopathy, familial hypertrophic type 19 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CALR3 Gene Cardiomyopathy, familial hypertrophic type 19 NGS Genetic DNA Test gene CALR3
Test Details

CALR3 gene cardiomyopathy, familial hypertrophic type 19 is a specific type of genetic test that is used to identify mutations in the CALR3 gene that are associated with familial hypertrophic cardiomyopathy (FHC) type 19.

Familial hypertrophic cardiomyopathy is a genetic disorder that affects the heart muscle, causing it to become thickened and making it harder for the heart to pump blood effectively. FHC type 19 is specifically caused by mutations in the CALR3 gene.

NGS (Next-Generation Sequencing) is a high-throughput genetic sequencing technology that allows for the simultaneous sequencing of multiple genes or even the entire genome. In the context of CALR3 gene cardiomyopathy, NGS is used to analyze the DNA of an individual to identify any mutations or variations in the CALR3 gene that may be associated with the development of FHC type 19.

This genetic test can be helpful in diagnosing individuals with familial hypertrophic cardiomyopathy type 19, especially in cases where the symptoms are not clear or when there is a family history of the condition. It can also be used for genetic counseling and to assess the risk of passing on the condition to future generations.

It is important to note that genetic testing should always be done under the guidance of a healthcare professional or genetic counselor who can provide appropriate counseling and interpretation of the results.

SKU: TEST-3401 Category:

Related products